Asset Details
Do you wish to reserve the book?
Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2
Do you wish to request the book?
Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2
1997
Overview
A significant proportion of human cancers express high levels of p53 protein in the absence of an underlying mutation in the gene. Using transformed (Vh1) and non-transformed (FRTL-5) rat thyroid epithelial cell lines as a model, we have examined the mechanisms by which high levels of wild-type p53 may be tolerated. Stable transfection with p53-dependent reporter constructs demonstrated that the 'excess' wild-type p53 in Vh1 cells is not associated with a comparable increase in p53-dependent transcription (though the response to u.v. irradiation is retained). Mdm-2, which binds p53 and inhibits its transactivation activity, is overexpressed in Vh1 cells in the absence of gene amplification and in a p53-dependent manner. Furthermore disruption of p53-mdm-2 complex formation in Vh1 cells by microinjection of an antibody to the p53-binding domain of mdm-2 resulted in a dramatic increase in p53-dependent transcription. Since only a small proportion of the p53 in Vh1 cells was found to be in complex with mdm-2 (the majority of unbound protein being in a latent form), this suggests that mdm-2 selectively binds a pool of p53 that would otherwise be active as a sequence-specific activator of transcription. We suggest that, in some types of tumour, the 'sensitivity' of the p53-driven mdm-2 feedback loop may be sufficient to prevent free, active p53 reaching the level required for growth arrest or apoptosis, making them an ideal target for therapies designed to disrupt p53-mdm-2 interactions.
Publisher
Nature Publishing,Nature Publishing Group
Subject
/ Biological and medical sciences
/ Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
/ Cell Transformation, Neoplastic
/ Fundamental and applied biological sciences. Psychology
/ Humans
/ Molecular and cellular biology
/ Proto-Oncogene Proteins - biosynthesis
/ Proto-Oncogene Proteins - physiology
/ Proto-Oncogene Proteins c-mdm2
/ Thyroid
/ Transcription Factors - physiology
/ Tumor Suppressor Protein p53 - metabolism
/ Tumor Suppressor Protein p53 - physiology
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.